IL125076A - Aza compounds, diazole cycloheptane and converted cyclooctane compounds and pharmaceutical preparations containing them - Google Patents

Aza compounds, diazole cycloheptane and converted cyclooctane compounds and pharmaceutical preparations containing them

Info

Publication number
IL125076A
IL125076A IL12507697A IL12507697A IL125076A IL 125076 A IL125076 A IL 125076A IL 12507697 A IL12507697 A IL 12507697A IL 12507697 A IL12507697 A IL 12507697A IL 125076 A IL125076 A IL 125076A
Authority
IL
Israel
Prior art keywords
alkyl
compound
halogen
substituted
phenyl
Prior art date
Application number
IL12507697A
Other languages
English (en)
Hebrew (he)
Other versions
IL125076A0 (en
Inventor
Hansjoerg Treiber
Stefan Blank
Dorothea Starck
Liliane Unger
Hansjuergen Teschedorf
Karsten Wicke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL125076A0 publication Critical patent/IL125076A0/xx
Publication of IL125076A publication Critical patent/IL125076A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
IL12507697A 1996-01-12 1997-01-10 Aza compounds, diazole cycloheptane and converted cyclooctane compounds and pharmaceutical preparations containing them IL125076A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19600934A DE19600934A1 (de) 1996-01-12 1996-01-12 Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
PCT/EP1997/000106 WO1997025324A1 (de) 1996-01-12 1997-01-10 Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung

Publications (2)

Publication Number Publication Date
IL125076A0 IL125076A0 (en) 1999-01-26
IL125076A true IL125076A (en) 2001-05-20

Family

ID=7782613

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12507697A IL125076A (en) 1996-01-12 1997-01-10 Aza compounds, diazole cycloheptane and converted cyclooctane compounds and pharmaceutical preparations containing them

Country Status (26)

Country Link
US (2) US6214822B1 (zh)
EP (1) EP0877744B1 (zh)
JP (1) JP4349657B2 (zh)
KR (1) KR100441073B1 (zh)
CN (2) CN1075070C (zh)
AR (1) AR005868A1 (zh)
AT (1) ATE273301T1 (zh)
AU (1) AU717726B2 (zh)
BG (1) BG64098B1 (zh)
CA (1) CA2241787C (zh)
CO (1) CO4790173A1 (zh)
CZ (1) CZ297981B6 (zh)
DE (2) DE19600934A1 (zh)
ES (1) ES2225947T3 (zh)
HR (1) HRP970021A2 (zh)
HU (1) HU228457B1 (zh)
IL (1) IL125076A (zh)
MX (1) MX9805499A (zh)
NO (1) NO316753B1 (zh)
NZ (1) NZ326332A (zh)
PL (1) PL327692A1 (zh)
SK (1) SK284987B6 (zh)
TR (1) TR199801302T2 (zh)
TW (1) TW475929B (zh)
WO (1) WO1997025324A1 (zh)
ZA (1) ZA97209B (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728996A1 (de) * 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
JP2002527433A (ja) 1998-10-08 2002-08-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ドーパミンｄ３受容体のモジュレーター（抗精神病薬）として有用なテトラヒドロベンズアゼピン誘導体
AR022230A1 (es) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
DE19922443A1 (de) * 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
US7037916B2 (en) 1999-07-15 2006-05-02 Pharmacopeia Drug Discovery, Inc. Pyrimidine derivatives as IL-8 receptor antagonists
ATE402704T1 (de) * 2000-03-27 2008-08-15 Abbott Gmbh & Co Kg Dopamin-d3-rezeptor-liganden zur behandlung von sucht
EP1632483B1 (en) 2001-02-16 2008-10-29 Aventis Pharmaceuticals Inc. Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10131543A1 (de) * 2001-06-29 2003-01-16 Abbott Lab Pyrimidinoxyalkylpiperazine und ihre therapeutische Verwendung
CN100462359C (zh) * 2001-11-28 2009-02-18 科学研究和应用咨询公司 5-硫烷基-4h-1,2,4-三唑衍生物及其作为药物的应用
DE60314730T2 (de) * 2002-03-15 2008-06-05 Ciba Specialty Chemicals Holding Inc. Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen
DE10304870A1 (de) * 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
DE10358004A1 (de) * 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
FR2877005A1 (fr) * 2004-10-22 2006-04-28 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
EP1846411A4 (en) * 2005-01-25 2010-08-04 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
EP2520567A3 (en) * 2006-02-23 2012-12-12 Shionogi & Co., Ltd. Nitrogen-containing heterocycle derivatives substituted with cyclic group
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
EP1882688A1 (en) 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
JP4840440B2 (ja) * 2008-12-24 2011-12-21 ソニー株式会社 画像処理装置およびその方法、並びにプログラム
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
CN102811620B (zh) * 2010-01-25 2015-03-25 Chdi基金会股份有限公司 一些犬尿氨酸-3-单加氧酶抑制剂、药物组合物及其使用方法
US9156822B2 (en) * 2010-07-02 2015-10-13 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine D2 receptors
WO2012065963A2 (en) 2010-11-15 2012-05-24 Katholieke Universiteit Leuven Novel antiviral compounds
BR112014004845A2 (pt) 2011-08-30 2017-04-04 Chdi Foundation Inc pelo menos uma entidade química; pelo menos um composto; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada
PL2750677T3 (pl) 2011-08-30 2017-12-29 Chdi Foundation, Inc. Inhibitory 3-monooksygenazy kinureninowej, kompozycje farmaceutyczne i sposoby ich stosowania
KR102412220B1 (ko) 2013-12-24 2022-06-23 온코타르티스, 아이엔씨. 벤즈아미드 및 니코틴아미드 화합물 및 이를 사용하는 방법
BR112017000922A2 (pt) 2014-07-17 2018-01-16 Chdi Foundation, Inc. métodos e composições para tratar distúrbios relacionados ao hiv

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE628766A (zh) 1962-12-26
BE792206A (zh) 1971-12-02 1973-06-01 Byk Gulden Lomberg Chem Fab
US5139998A (en) 1988-08-31 1992-08-18 Superconductor Technologies, Inc. Controlled thallous oxide evaporation for thallium superconductor films and reactor design
SE8803429D0 (sv) 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
FR2663638B2 (fr) 1990-04-06 1995-02-10 Institut Nal Sante Recherc Medic Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
JP2518965B2 (ja) 1990-09-21 1996-07-31 三井東圧化学株式会社 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
FR2668771B1 (fr) 1990-11-06 1995-03-17 Inst Nat Sante Rech Med Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
DE4425145A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE4425146A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
FR2742149B1 (fr) 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
IL125076A0 (en) 1999-01-26
BG64098B1 (bg) 2003-12-31
ES2225947T3 (es) 2005-03-16
KR100441073B1 (ko) 2004-11-16
SK94198A3 (en) 1999-03-12
DE59711847D1 (de) 2004-09-16
CN1075070C (zh) 2001-11-21
TW475929B (en) 2002-02-11
PL327692A1 (en) 1998-12-21
CZ215998A3 (cs) 1999-05-12
ATE273301T1 (de) 2004-08-15
TR199801302T2 (xx) 1998-11-23
US6352981B1 (en) 2002-03-05
AR005868A1 (es) 1999-07-21
NZ326332A (en) 1999-04-29
AU717726B2 (en) 2000-03-30
NO983187L (no) 1998-09-09
CO4790173A1 (es) 1999-05-31
EP0877744B1 (de) 2004-08-11
HU228457B1 (en) 2013-03-28
CN1212692A (zh) 1999-03-31
HUP9901590A3 (en) 2002-01-28
HRP970021A2 (en) 1998-04-30
CN1146551C (zh) 2004-04-21
AU1440797A (en) 1997-08-01
CN1348956A (zh) 2002-05-15
JP4349657B2 (ja) 2009-10-21
CZ297981B6 (cs) 2007-05-16
HUP9901590A2 (hu) 1999-08-30
DE19600934A1 (de) 1997-07-17
JP2000505072A (ja) 2000-04-25
KR19990077127A (ko) 1999-10-25
CA2241787A1 (en) 1997-07-17
NO316753B1 (no) 2004-04-26
US6214822B1 (en) 2001-04-10
CA2241787C (en) 2006-04-04
BG102616A (en) 1999-04-30
EP0877744A1 (de) 1998-11-18
SK284987B6 (sk) 2006-04-06
MX9805499A (es) 1998-11-30
ZA97209B (en) 1998-07-10
WO1997025324A1 (de) 1997-07-17

Similar Documents

Publication Publication Date Title
IL125076A (en) Aza compounds, diazole cycloheptane and converted cyclooctane compounds and pharmaceutical preparations containing them
KR102366670B1 (ko) O-아미노헤테로아릴알키닐기를 함유한 화합물 및 이의 제조 방법과 용도
JP5560278B2 (ja) キナーゼ阻害剤として有用なイミダゾピリダジンカルボニトリル
EP2960233A1 (en) New therapeutic agents
BG63487B1 (bg) Използване на хетероциклени съединения
GB2286395A (en) Pharmaceutical piperazines
CS247073B2 (en) Production method of 2-substituted 4-amino-6,7-dimethoxyghinolins
EP2617717B1 (en) P2x4 receptor antagonist
JPH0739387B2 (ja) 新規１−ベンジル−アミノアルキル−ピロリジノン化合物及びその製造方法
JP5049134B2 (ja) ドーパミンｄ３受容体の調節に応答する障害の治療に好適なトリアゾール化合物
US5308844A (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazin-4-ones and their use in therapy
HRP20010969A2 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for preparation of the active substance
EP1638943B1 (fr) NOUVEAUX DERIVES D’IMIDAZOLES, LEUR PREPARATION ET LEUR UTILISATION EN TANT QUE MEDICAMENT
WO2008022747A1 (en) Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
SK283489B6 (sk) Piperazinylalkyltiopyrimidínové deriváty, spôsob ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie
FI76794C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spirotiazolidindionderivat.
JP3786983B2 (ja) ピロリジノン誘導体
JPH10306078A (ja) ウレア誘導体
JP2002205987A (ja) アシルアミノシクロプロパン誘導体
JP5539322B2 (ja) Ｃｂ−１リガンドとしての１，５−ジフェニル−ピロリジン−２−オン化合物
CA2293480A1 (en) 2-aminoalkylaminoquinolines as dopamine d4 ligands
FR2877005A1 (fr) Nouveaux derives d'arylpiperazine
MXPA00009479A (es) Nuevos heterociclos de 6 anillos sustituidos con difenilo, procedimiento para su preparacion, asi como su empleo como medicamentos.
CN117362231A (zh) 一种取代脒类化合物的合成方法及其用途
JP3786985B2 (ja) ピロリジノン誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired